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Abstract
 .A biochemically distinct form of cytochrome oxidase COX deficiency found in the Saguenay region of Quebec is an
autosomal recessive trait. The cDNA sequences of all 10 nuclear-encoded subunits from a patient’s fibroblasts showed
normal coding sequence. Sequences for subunit VIc in two atypical patients showed a heterozygous base substitution.
Subunit VIc was localized to chromosome 18. q 1998 Elsevier Science B.V.
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1. Introduction
Leigh’s syndrome, or subacute necrotizing en-
cephalomyelopathy, is one of the inherited conditions
caused by a deficiency of Complex IV of the respira-
 .tory chain, cytochrome oxidase COX . COX is a
multisubunit protein consisting of three subunits
which are encoded in mitochondrial DNA which is
maternally inherited and an additional 10 subunits
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w xwhich are encoded in the nucleus 1 . A form of
Leigh’s disease found within the geographically iso-
 .lated region of Saguenay Lac Saint Jean SLSJ ,
Quebec, is characterized by severe COX deficiency
in liver and brain and 50% of normal in fibroblasts
w xand skeletal muscle 2 . The presence of normal
mRNA levels for the subunits in liver and fibroblasts
w xsuggests that transcriptional processes are intact 3 .
The clinical features of a typical SLSJ COX patient
include moderate developmental delay, hypotonia,
ataxia, strabismus, and mild facial dysmorphism. Most
children die with fulminant metabolic acidosis before
w xthe age of 5 years 3 . The inheritance pattern is
w xautosomal recessive 3 . Two atypical patients, desig-
nated as 3516 and 5828 in this study, show typical
0925-4439r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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Table 1
The forward and reverse primers used for the PCR amplification of cDNA for the 10 nuclear-encoded subunits of human COX
Subunit Forward primer Reverse primer
X X X XIV 5 -AGAATGTTGGCTACCAGGGT-3 5 -ATAGGCATGGAGTTGCATGG-3
X X X XVa 5 -CCATCGCCGTCATGCTGGGCG-3 5 -CCATGCGGTTTACACTTTGTC-3
X X X XVb 5 -ATGGCTTCAAGGTTACTTCGC-3 5 -TAGTGCAGGTGCTCAGTGTG-3
X X X XVIa 5 -GTGGATCCTCGGTTTCTCGGCT-3 5 -TGCTGCAGTCCCTGGTGCCCG-3
X X X XVIb 5 -ATGGCGGAAGACATGGAGAC-3 5 -TCACCATCCTGGGAGAAGGA-3
X X X XVIc 5 -AGGACGTTGGTGTTGAGGTTA-3 5 -ATCAAGAGGAACTATTCTTAG-3
X X X XVIIa 5 -CCAAGATCCTGCGGAATCTGCTG-3 5 -AAGAGCTCGGTTATTTATCAGAT-3
X X X XVIIb 5 -TCACTTCAAGGGTACCTGAAG-3 5 -CCATATCTTAATGGGTACACAG-3
X X X XVIIc 5 -CAGAGCTCCCAGCGGCTATGTTGGGCCA-3 5 -ATGAATTCTAGTTTGATCCACTTCCAG-3
X X X XVIII 5 -GTACTCCGTGCCATCATGTC-3 5 -AAGAGGTCATGATTGCAGAAG-3
delayed developmental phenotypes but are now 15
years of age and in otherwise good health.
2. Discussion
Fibroblast cell lines 8356, a typical SLSJ COX
.deficient patient, and 8972, a healthy control were
cultured in a-MEM, 2=glucose, uridine and col-
lected at 85% to 90% confluency for RNA isolation
using GIBCO’s Trizol kit. Final RNA precipitates
were resuspended in 50 ml DEPC–H O and stored at2
y808C supplemented with 1 ml Pharmacia’s RNase
Inhibitor. Reverse transcription of the mRNA 10
.  .mg was carried out using an oligo dT primer in20
first strand buffer 25 mM Tris–HCl, 37.5 mM KCl,
.1.5 mM MgCl , 1 mM DTT with M-MLV reverse2
transcriptase. The cDNA sequences for the liver spe-
cific COX nuclear subunits were PCR amplified us-
ing primers designed from published cDNA se-
 .quences Table 1 . The PCR fragments were ligated
into pCRe vectors, and potential transformants were
initially screened via PCR. Several, positive isolates
were sequenced using Pharmacia’s T7 sequencing kit
with forward and reverse primers.
All of the nuclear-encoded COX subunit cDNA
sequences for 8356 showed no abberations from the
w xpublished data 4–13 except for a polymorphism
found in the sequence for subunit VIc. At base 222, a
C to T substitution was found in both patient and
control samples, which differs from the published
w xresults 4 . This translates into an amino acid change
from a serine to a phenylalanine. Such polymor-
phisms imply the presence of some differences in the
sequences of these subunits between individuals
andror populations.
Fig. 1. A representative autoradiograph showing the base substitution in subunit VIc resolved by DNA sequencing. Both mRNA and
genomic DNA were isolated from fibroblast cultures using GIBCO’s Trizol method. The mRNA was used to synthesize the cDNA via
reverse transcriptase. Both cDNA and genomic DNA were used as templates in the PCR of subunit VIc using the primers as indicated in
Table 1. The 390 base pair product was cloned into Invitrogen’s pCRe vector and sequenced with Pharmacia’s T7 polymerase
 .  .sequencing kit. The sequences shown above are for cell lines a 3516 and b 8972. The sequence for 5828 also showed the same change
as 3516. The base substitution in base 258 changes a glutamic acid to glycine.
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Fig. 2. A ribbon diagram of the X-ray crystallography of bovine COX in the vicinity of Glu-62 and Lys-58 of subunit VIc and Lys-127 of
subunit IV. Subunit VIc is depicted by the center peptide. Subunit II sits on the left side of VIc and subunit IV is to the right of VIc.
Glu-62 forms ionic interactions with VIc-Lys-58 and IV-Lys-127 which pulls the cytoplasmic C-terminus of subunit VIc into the region
flanked by subunits II and IV.
Sequencing analysis of cDNA for subunit VIc
from fibroblast cell lines of the atypical patients,
5828 and 3516, showed a heterozygous abberation in
both cDNA and genomic DNA which was not ob-
 .served in control cell line 8972 nor classical Leigh’s
 .cell line 3840 nor in the other SLSJ COX defi-
ciency patients. The change involved a base substitu-
 .tion at base 258 from an adenine to a guanine Fig. 1
 .which replaces a glutamic residue Glu-62 with a
glycine 12 amino acid residues away from the C-
Fig. 3. Human chromosomal localization of the sequence of subunit VIc. Human chromosomes within mouse and hamster backgrounds
were used as templates to PCR amplify the sequence for subunit VIc. The chromosome number within the hybrid is designated for each
lane. Hu represents all chromosomal hybrids. Mo represents mouse genomic DNA. Ha represents hamster genomic DNA. Pharmacia’s
low molecular weight ladder f x-174 RF DNA-HaeIII digest was used for the size standards. The brightest band of the expected size 390
.bpr is on chromosome 18. Fainter, smaller bands were found on chromosome 14 and 16.
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terminus. This substitution was observed using differ-
ent sequencing primers in both directions.
The heterozygous substitution was also present in
parental DNA of these patients, implying that these
parents are at least carriers for this mutation. How-
ever, only the children show the COX clinical pheno-
type. This implies that the gene defect causing the
disease is somehow tempered by the A258G base
change. One possibility is that the mutation for the
disease is affecting assembly and the A258G muta-
tion is partially reversing that effect. For instance, the
key mutant protein affecting assembly of COX per-
haps has difficulties associating with the subunit VIc
in the assembly process. The A258G mutation could
alter the configuration of subunit VIc allowing the
factor to improve its efficacy in COX assembly or
stability.
This notion is further supported by structural anal-
ysis of the X-ray crystallography data of bovine COX
w x14 . Glu-62 forms ionic interactions with Lys-127 in
 .subunit IV and Lys-58 in subunit VIc Fig. 2 . This
allows the cytoplasmic side of VIc to nestle in a
groove formed by the adjacent subunits II and IV. If
these interactions are obfuscated by the glycine sub-
stitution, the C-terminus tail of VIc would be more
 .accessible to any protein s which may interact with
it. These individuals with the A258G substitution
may then express VIc subunits which partially re-
verse the effect of the gene defect causing this dis-
ease because of the increased accessibility to an
assembly factor. Since the VIc mutation may affect
the overall activity of COX, a search for the protein
or proteins that interact with subunit VIc is being
carried out with the yeast two-hybrid system. The
target subunit VIc protein is being screened with the
expression products of a human cDNA library. Any
interacting proteins may be the modulators of COX
which affect this disease.
3. Conclusion
Since the same primers used for the cDNA tem-
plate amplified the same sized product for the ge-
nomic DNA template, the primers were used in the
chromosomal localization of the sequence for VIc.
The major product was found to be on chromosome
18, comparable to the predicted size of 390 base pairs
 .Fig. 3 . Two minor bands were found in the lanes
for chromosome 14 and 16. The size of the PCR
product from the chromosomal localization verifies
that this gene may be void of introns as it is the same
length as the PCR product from cDNA. The fainter
bands seen in the chromosomal localization implies
the presence of pseudogenes of VIc on chromosomes
14 and 16.
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